---
title: FCF Biotech Venture Capital Monitor - USA 11/2023 published - FCF Fox Corporate Finance GmbH
description: FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more
---

[Research ](https://www.fcf.de/en/resources/research)

# [FCF Biotech Venture Capital Monitor - USA 11/2023 published - FCF Fox Corporate Finance GmbH](https://www.fcf.de/en/resources/research/fcf-biotech-venture-capital-monitor-usa-11-2023-published)

 Written by [FCF Healthcare & Life Sciences](https://www.fcf.de/en/resources/research/author/fcf-healthcare-life-sciences) | Jan 8, 2024 7:00:00 AM

FCF Fox Corporate Finance GmbH is delighted to publish the new “**FCF Biotech Venture Capital Monitor – USA 11/2023**”.

The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector.

**As of the end of November 2023, we identify the following current VC trends in the US-Biotech sector:**

- In 2023, overall Biotech funding in the USA has reached USD 21,391m
- Compared to November 2022 the financing volume decreased by roughly 28% (29,739m vs. 21,391m)
- The top 5 deals exceed USD 273m each, the largest transaction amounted to USD 401m with ElevateBio
- Terremoto Biosciences has the highest transaction Volume of USD 175m in November, followed by Kyverna USD 152m and Cognito Therapeutics USD 129m
- ARCH Venture Partners (USA) is leading the Top 5 Investors (by deal volume), followed by RA Capital Management (USA) and OrbiMed (USA)
- As an indication oncology records the highest investment activity

To access the full report, please click [here](https://www.fcf.de/resources/research/download-request-fcf-healthcare-life-sciences-research-series-usa?hsLang=en).

[View full post](https://www.fcf.de/en/resources/research/fcf-biotech-venture-capital-monitor-usa-11-2023-published)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "FCF Healthcare & Life Sciences"
  },
  "dateModified" : "2025-11-11T15:51:47.969Z",
  "datePublished" : "2024-01-08T07:00:00Z",
  "headline" : "FCF Biotech Venture Capital Monitor – USA 11/2023 published",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2666,
    "url" : "https://145785926.fs1.hubspotusercontent-eu1.net/hubfs/145785926/Website/Ressourcen/Healthcare_USA-Monitor_Shutterstock_2422998617_reduziert.jpeg",
    "width" : 4000
  },
  "mainEntityOfPage" : "https://www.fcf.de/en/resources/research/fcf-biotech-venture-capital-monitor-usa-11-2023-published",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Research"
  }
}
```